The Latest Breaking News from Mounjaro

Novo Nordisk’s (NYSE:NVO) nearly 11% pre-market drop on Monday and subsequent 9% dip at market open, in the aftermath of disappointing topline results from its evoke/evoke+ Alzheimer’s trials, is more than a pipeline setback.  It’s a stress test for healthcare ETFs that have quietly become GLP-1 momentum vehicles. With two…

"I used science and support (shoutout to Mounjaro!) to help me after my 2nd pregnancy,” said the singer, who became famous for embracing her curves in 'All About That Bass.'

As the battle for dominance heats up in the weight loss market, which stock is a better investment now?

Eli Lilly CEO says Britain’s strict regime means it could miss out on new drugs being rolled out unless it pays more

Carly Stokes, who has dropped 6st in a year using the weight-loss jab, will now have to pay £319 a month

Rhiannon Anne Griffiths-Bowen says the weight-loss benefits of taking Mounjaro outweighed the issue of hair loss

People using the jab reported positive results, but many say the increased cost will be prohibitively expensive, and they expect to put the weight back on when they stop

Cost may increase as much as 170% from September, but patients warned against a quick switch to Wegovy

COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous – impact on Britain’s pharmacies and patients, writes Leyla Hannbeck, CEO of the Independent Pharmacies Association